​Turning ideas into innovation, research and development (R&D) is the lifeblood of the life sciences industry. In an increasingly competitive environment, a company’s survival is almost wholly dependent on the discovery and development of new products, including medicines, vaccines and medical devices. Research and development is a serious investment in time and money – on average, large multinational drug companies spend 17% of their revenues of R&D, while it takes ten years on average to bring a new drug to market.

Thanks to investment in talent and technology, as well as collaborative efforts of researchers, designers, engineers, manufacturers and regulators, companies worldwide continue to bring thousands of novel products into being for the benefit of individuals and wider society. The latest release of DrugBank contains over 13,000 approved rug entries that are available in the global market. According to a report from the World Health Organization there are more than 10,000 types and 1.5 million pieces of medical devices or equipment available today.

Myles Whiting, design team leader at medical device company Owen Mumford, echoes the importance of this collaborative effort in research and development, “Product designers must work with marketing teams to establish unmet market and customer needs, then marketing teams interpret and deliver market context and customer needs to the engineers, who then have the ability to process this into measurable design input. The research and information is gathered, this is then accumulated into a brief which the designer uses to address the market or customer need.”

Technological advancements have reduced the cost of research and development – helping to accelerate investment in life sciences – while also creating new opportunities for product innovations as the Fourth Industrial revolution blurs the boundaries between the biological, physical and digital worlds. According to a report by KPMG, the cost of drug R&D will drop by 2030, leading to numerous benefits for the both the industry and consumer in terms of cost savings.

While regulators play catchup, companies are rushing to capitalize on the booming sector. A recent survey of 543 medical device executives in North America, Europe and Asia by Emergo, suggests the sector is pushing forward with aggressive investment. The majority of survey participants (53%) indicated they would increase their R&D investments over the next 12 months and more than 70% of survey respondents say they will begin R&D efforts on multiple new devices over the next 12 months. Globally, R&D spending in medical device is anticipated to grow by 4.5% to hit $39bn by 2024. Meanwhile, the pharmaceutical industry is forecasted to reach $181bn by 2022, growing at an average rate of four percent year on year.

Deloitte reports that advanced technologies and innovations such as robotics, artificial intelligence, automation, real-world evidence, digital health and telemedicine, can impact R&D across the entire value chain –from drug discovery to clinical trials and regulatory reporting.

If you're a candidate, please register your CV and get discovered for all relevant roles.

Register your CV

If you're a client looking for the best talent, please Register your vacancy or Request a call back.

Register your vacancy
Request a call back

​Benefits of working with us


We have over a decade’s worth of experience as a leading talent partner in Clinical Development


A vast, global network of the best, in-demand professionals, working with the world’s largest Life Sciences institutions, to take drugs, devices and therapeutic applications through from conception to completion.


Our award-winning talent specialists offer bespoke, tailored guidance on the latest hiring trends and industry news to help you achieve your goals.

Current R&D Jobs

Head of Formulation Development
Negotiable, Switzerland

Head of Formulation Development Role: Formulation Development - Group Lead Salary: Competitive Lo...

Apply now
USP Manager
Negotiable, Italy

Upstream Development Manager Role: Upstream Development Manager Salary: Competitive Location: Ita...

Apply now
Head of Formulation Development
Negotiable, Munich

Head of Formulation Development (m/f/d) Salary: Competitive Location: Munich - Hybrid (Company ca...

Apply now
Head of Analytical Development
Negotiable, Munich

Head of Analytical Development Salary: Competitive Location: Germany - Munich I am currently work...

Apply now
Pharmaceutical Validation Manager
Negotiable, Raleigh

A GMP Validation Engineer Manager the primary responsibility is to ensure that the manufacturing ...

Apply now
Senior Scientist
Negotiable, Singapore

Title: (Senior) Scientist - mRNA Production Location: Singapore Overview: We are partnered with a...

Apply now
(Associate) Director, Process Development (Antibody)
US$180000 - US$220000 per annum, San Francisco

AD/Director of Process Development Company Summary: A small antibody engineering company is curre...

Apply now
Upstream Process Development Principal Scientist/AD/Director
Negotiable, Boston

Upstream Process Development Principal Scientist/AD/Director Company Summary: An established biot...

Apply now
Senior Quality Specialist
US$40 - US$48 per hour, Long Beach

**Onsite Role in Cypress, CA** Job opportunity with a top biopharmaceutical company that is looki...

Apply now